High materiality7/10
Belite Bio price target raised to $214 from $200 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises BLTE target to $214 from $200; current price $177.58.
- BLTE target raised to $214; price $177.58.
- Analyst: Yi Chen
Key facts
- 01
Target: $214
- 02
Posted price: $177.58
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Yi Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.